Looking for treatment? Call or text (888) 835-9995 to start care today — or return to the homepage.
How long should someone stay on Suboxone?
People often ask this in two ways: how long people typically stay on Suboxone, and how long they personally should remain on it. The answer is the same — it is individualized.
Most people who do well on Suboxone (buprenorphine) stay on it for an extended period. Some stop. Many do not.
There is no required cutoff. Treatment length is based on clinical stability and individual factors — not a fixed timeline. There is no standard suboxone schedule, no set suboxone course, and no recommended length of therapy that applies to everyone.
What guidelines say
There are no recommended time limits.
SAMHSA and ASAM — the two primary bodies setting addiction medicine standards — both advise against arbitrary limits on buprenorphine treatment. The duration of treatment is individualized. No suboxone timeline applies universally.
The older model — a short treatment period followed by discontinuation — is no longer considered evidence-based. Opioid use disorder is a chronic condition. Stopping medication prematurely produces outcomes similar to stopping treatment for any other chronic disease.
A 2020 study in JAMA Psychiatry found that patients who remained on buprenorphine had lower rates of overdose and emergency care use compared to those who discontinued.
What determines duration
It is individualized.
Several factors influence how long a patient remains on suboxone therapy:
Stability and life context
Patients with stable housing, employment, and support systems have more flexibility in considering tapering. Patients in unstable or high-risk environments generally benefit from continuing medication.
Length and severity of prior opioid use
Longer histories of opioid use — especially with prior return to use after treatment — are associated with better outcomes on longer treatment.
Co-occurring conditions
Depression, anxiety, PTSD, and related conditions increase risk of return to use when medication is stopped. These factors directly influence treatment duration decisions.
Patient preference
Patient preference is a clinical variable. A patient choosing to taper with preparation is different from a patient stopping due to external pressure.
Duration
There is no standard suboxone duration.
There is no evidence-based point at which suboxone therapy should be stopped. Current guidelines do not recommend time limits on the duration of treatment.
Short suboxone courses are associated with worse outcomes. Longer treatment is associated with better outcomes.
Many patients remain on buprenorphine for extended periods. That is standard care.
Some patients stop. Some do not. The decision is individualized.
Stopping treatment
Stopping is not the goal of treatment.
Buprenorphine does not need to be tapered simply because a patient has been stable. Stability is not a reason to stop a medication that is working.
If tapering is considered, it is a clinical decision — not something driven by timelines or external pressure.
When tapering is appropriate, it is gradual. Abrupt discontinuation increases risk of return to use and overdose.
When a patient and physician decide it's appropriate to taper off buprenorphine, the process is gradual — not abrupt. Tapering schedules are typically slow, with dose reductions measured in small increments over weeks or months, not days. The slower the taper, the more comfortable it tends to be.
Stopping Suboxone without a plan — especially abruptly — significantly increases return to use risk. Withdrawal from buprenorphine is milder than withdrawal from full opioid agonists, but it's still uncomfortable and can last longer due to buprenorphine's long half-life.
If you're considering stopping or tapering, that conversation starts with your prescriber — not on your own. A slow, supervised taper with a plan in place is meaningfully safer than stopping independently.
The question is not how long someone has been on buprenorphine. The question is whether it is still helping.
Sources
Where this information comes from.
ASAM National Practice Guideline (2023)
Updated ASAM guidance on duration of buprenorphine treatment, tapering, and individualized care planning.
SAMHSA TIP 63: Medications for Opioid Use Disorder
Federal clinical guidelines on buprenorphine treatment length, patient selection, and tapering protocols.
Wakeman et al., JAMA Psychiatry (2020)
Comparative effectiveness study showing reduced overdose and emergency visits among patients who remained on buprenorphine treatment.
HHS: Opioid Treatment Resources
Federal treatment resource hub including medication-assisted treatment guidance and patient support tools.
Related
← All Learn topics · How long Suboxone lasts (pharmacology) · Starting Suboxone · How long does buprenorphine take to work? · How to get Suboxone online
MyStreetHealth serves
Virginia · Maryland · Washington DC · West Virginia · Ohio
Common questions
Frequently asked
Is there a maximum time you can take Suboxone?
No. There's no medically established maximum. Buprenorphine is safe for long-term use and current guidelines do not recommend time limits on treatment.
What happens if I stop Suboxone suddenly?
Stopping abruptly can cause withdrawal symptoms and significantly raises return to use risk. A supervised, gradual taper is always the safer approach. Talk to your physician before making any changes.
How do I know when I'm ready to taper?
Readiness for tapering is a clinical conversation — not something with a simple checklist. Stability in housing, relationships, mental health, and absence of cravings are relevant factors. Your prescriber can help you assess where you are.
Does insurance limit how long I can get Suboxone?
Some insurers have historically imposed limits, but federal parity laws and updated guidance have reduced this significantly. MyStreetHealth operates on a self-pay model, so insurance restrictions don't apply to care through us.
Also on this site